FdaApplication

ANDA 215949

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNOVITIUM PHARMA LLC
application_typeANDA
approval_date2023-03-03

Products (3)

ProductActive ingredientStrengthDosage form
TADALAFILTADALAFIL5MGTABLET;ORAL
TADALAFILTADALAFIL20MGTABLET;ORAL
TADALAFILTADALAFIL10MGTABLET;ORAL

3 products